(Press-News.org) Researchers have shown that point mutations – mis-spellings in a single letter of genetic code – that drive the onset and growth of cancer cells can be detected successfully in advanced ovarian cancer using a technique called OncoMap. The finding opens the way for personalised medicine in which every patient could have their tumour screened, specific mutations identified, and the appropriate drug chosen to target the mutation and halt the growth of their cancer.
Using mass spectrometry for identifying the genetic make-up of cancer cells, OncoMap can determine the point mutations in a large panel of over 100 known cancer-causing genes (oncogenes) in tumours. In the work to be presented today (Wednesday) at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin, researchers will describe how they used OncoMap to identify mutations in oncogenes in tumour samples from women with advanced high-grade serous ovarian cancer. Earlier in the year 76 mutations in 26 different genes had been found but, since then, further work in more tumour samples has found more.
Dr Ursula Matulonis, director/program leader in medical gynaecologic oncology at the Dana Farber Cancer Institute in Boston (Massachusetts, USA) and Associate Professor of Medicine at Harvard Medical School, will tell the meeting: "Epithelial ovarian cancer is the most lethal of all the gynaecologic malignancies, and new treatments are needed for both newly diagnosed patients as well as patients with recurrent cancer. The success of conventional chemotherapy has reached a plateau, and new means of characterising ovarian cancer so that treatment can be personalised are needed.
"We know that many human cancers have point mutations in certain oncogenes, and that these mutations can cause cancer cells to have a dependence on just one overactive gene or signalling pathway for the cancer cell's growth and survival – a phenomenon known as 'oncogene addiction'. If the mutation that causes the oncogene addiction can be inhibited, then it seems that this often halts the cancer process. Examples of mutations that are successfully inhibited by targeted drugs are HER2 (for which trastuzumab is used in breast cancer), EGFR (erlotinib in lung cancer) and c-kit (imatinib in chronic myeloid leukaemia). So if we know the status of specific genes in a tumour, then this enables us to choose specific treatments that are likely to work successfully against the cancer."
Dr Matulonis and her colleagues used OncoMap to investigate the mutation status of high-grade serous ovarian tumours that were known not to be caused by inherited mutations in the BRCA 1/2 genes. They found mutations previously identified to be involved in ovarian cancer: KRAS, BRAF, CTNNB1 and PIK3CA. The KRAS and PIK3CA mutations were the most common, while BRAF was more rare. The researchers also identified a low frequency of mutations in many other different oncogenes.
"This study shows that it's feasible to use OncoMap to identify whether a patient's tumour has a mutation in an oncogene for which a known drug is available to target that specific gene, so as to enable us to place her on a clinical study of that drug; for instance, XL147 or GDC0941 are inhibitors for the P13kinase mutation that are in clinical trials at present," said Dr Matulonis. "In addition, someone's cancer could harbour a mutation (such as ALK) that is not known to be associated with ovarian cancer or has not yet been studied in ovarian cancer – these patients could be matched with a drug that inhibits that protein too. As new drugs get developed, this information would be used to match future drugs with patients and their cancers."
The researchers hope that OncoMap will become a clinical test for all cancer patients at the Dana Farber Cancer Institute before long, so that the genetic information obtained can be used to choose the best treatment for them.
"At present, only a few targeted therapies are being used for newly diagnosed ovarian cancer and most are being used to treat recurrent ovarian cancer, but this will change eventually. I have already referred several of our patients who are either newly diagnosed or have recurrent cancer and who have mutations (one with KRAS and one with PIK3CA) to our phase I programme for drugs studies specific to these mutations," said Dr Matulonis.
She believes that OncoMap and other similar analytical tools will become mainstream practice in all cancer clinics before long. Tools for detecting genes with the incorrect numbers of copies or abnormal expression will also help doctors to choose the best treatment for individual patients.
"For ovarian cancer, understanding mutational analysis is one piece of the genetic puzzle. Our group will also start looking for chromosomal and gene amplifications and deletions in patients' tumours, which we know are important for ovarian cancer."
###
Abstract no: 35. Oral presentation in plenary session 2, Rooms A-C, 14.45-16.15 hrs CET, Wednesday 17 November.
Notes:
[1] EORTC [European Organisation for Research and Treatment of Cancer, NCI [National Cancer Institute], AACR [American Association for Cancer Research].
[2] The study was funded by the Madeline Franchi Ovarian Cancer Research Fund, twoAM Fund and the Sally Cooke Ovarian Cancer Research Fund.
END
Scientists believe they may have found a new target for treating triple negative breast cancer – one of the more difficult breast cancers to treat successfully and for which there is no targeted therapy at present.
Triple negative breast cancer (TNBC) is a cancer that does not express receptors for oestrogen (ER), progesterone (PR) or the human epidermal growth factor (HER2). It tends to be more aggressive, occurs more often in younger women, and is difficult to treat successfully as it lacks the receptors that currently available targeted therapies such as tamoxifen ...
Washington, D.C. (November 16, 2010) -- For more than 250 years, researchers have known that under certain conditions vapor bubbles can form in fluids moving swiftly over a surface. These bubbles soon collapse with such great force that they can poke holes in steel and damage objects such as ship propellers, turbine blades, nozzles and pump impellers.
Scientists have conducted extensive research for decades to try to understand this phenomenon -- called cavitation. But most experiments to date have been related to open-water objects like ship propellers.
Now a group ...
Washington, D.C. (November 16, 2010) -- While our direct knowledge of black holes in the universe is limited to what we can observe from thousands or millions of light years away, a team of Chinese physicists has proposed a simple way to design an artificial electromagnetic (EM) black hole in the laboratory.
In the Journal of Applied Physics, Huanyang Chen at Soochow University and colleagues have presented a design of an artificial EM black hole designed using five types of composite isotropic materials, layered so that their transverse magnetic modes capture EM waves ...
Washington, D.C. (November 16, 2010) -- In a move that holds great significance for the semiconductor industry, a team of researchers has created an alternative to conventional logic gates, demonstrated them in silicon, and dubbed them "chaogates." The researchers present their findings in Chaos, a journal published by the American Institute of Physics.
Simply put, they used chaotic patterns to encode and manipulate inputs to produce a desired output. They selected desired patterns from the infinite variety offered by a chaotic system. A subset of these patterns was ...
CINCINNATI—Researchers at the University of Cincinnati (UC) have found that fat around the outside of arteries may lead to the development of cardiovascular disease and could be linked to its onset in individuals with diabetes.
David Manka, PhD, a researcher in the division of cardiovascular diseases, and his team found that this fat—known as perivascular adipose tissue—could possibly lead to the formation of fatty buildup inside of arteries and could cause existing buildup to break loose, leading to stroke or heart attack.
These findings are being presented at the ...
The increase in the legal age of sexual consent from 14 to 16 years in 2008 may not be protecting those at greatest risk, according to researchers who have analyzed British Columbia population-based data and recommend additional strategies to safeguard vulnerable children and teens.
In the first study of its kind in Canada, researchers from the University of British Columbia and Simon Fraser University tested the government's reasons for changing the law. Their findings are published in the current issue the Canadian Journal of Human Sexuality.
According to the study's ...
Risø Energy Report 9 lists a wide range of energy technologies in the market with low or no emissions of greenhouse gases, describing how several of these will be made commercially available in the next decades.
However, it is not possible to make the world's energy supply CO2-free as cheaply as possible, using only technology development in the current energy systems. There must be room for technological leaps and there is a need for an integrated process to optimise the entire energy system, from energy production, through transformation into energy carriers, to energy ...
Long-nosed Cape rock elephant-shrews are fond of sticky treats, according to Dr. Petra Wester from the University of Stellenbosch in South Africa. Her investigations show for the first time that the elephant-shrew, Elephantulus edwardii, licks the nectar of the flowers and pollinates the Pagoda lily. Her results are published in Springer's journal, Naturwissenschaften – The Science of Nature.
Dr. Wester studied the behavior of the animals in the northern Cederberg area of South Africa, where Pagoda lily plants, Whiteheadia bifolia (Hyacinthaceae), are found in shady rock ...
CINCINNATI—University of Cincinnati (UC) researchers have discovered a new protein that could be cardioprotective during heart attack, potentially leading to more targeted treatments for patients at risk.
These findings are being presented at the American Heart Association's (AHA) Scientific Sessions in Chicago Nov. 16.
Researchers in the department of pharmacology and cell biophysics, led by Chi Keung Lam, a PhD student, and Wen Zhao, PhD, under the direction of Litsa Kranias, PhD, AHA distinguished scientist and chair of the department, found that HAX-1, an anti-cell ...
For Immediate Release – November 16, 2010 – (Toronto) – A new study from the Centre for Addiction and Mental Health (CAMH) has found that 29,000 Ontario students from grades 7-12 report behaviours indicating that they are gambling problematically. The study also found that more than two-thirds of these students reported problems with substance use and/or alcohol use, and 25% reported a suicide attempt in the past year.
The Ontario Youth Gambling Report looked at self-report data from over 9,000 students across Ontario to monitor trends and areas for concern regarding ...
